Indication of endovascular treatment of type B aortic dissection - Literature review

Detalhes bibliográficos
Autor(a) principal: Duarte,João Jackson
Data de Publicação: 2014
Outros Autores: Pontes,José Carlos Dorsa Vieira, Benfatti,Ricardo Adala, Ferrachini,Adriana Lugo, Karakhanian,Walter Kegham, Razuk Filho,Álvaro
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Cardiovascular Surgery (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000300396
Resumo: Aortic dissection is a cardiovascular event of high mortality if not early diagnosed and properly treated. In Stanford type A aortic dissection, there is the involvement of the ascending aorta, whereas in type B the ascending aorta is not affected. The treatment of type A aortic dissection is mainly surgical. The hospital mortality of type B aortic dissection surgical treatment is approximately 20%, while medical therapy is 10%. However, half the patients who are discharged from hospital after medical treatment, progress to aortic complications in the following years, and the mortality in three to five years may reach 25-50%. In addition, the surgical treatment of aortic complications after medical treatment, has also a significant mortality. This way, the endovascular treatment comes up as an interesting alternative of a less invasive treatment for this disease. They presented a mortality rate lower than 10% with more than 80% success rate of occlusion and thrombosis of the false lumen. The INSTEAD TRIAL, which randomized patients with uncomplicated type B aortic dissection for optimal medical therapy and endovascular treatment in addition to optimal medical therapy, showed that after three years of follow up, patients who underwent endovascular treatment had lower mortality and aorta-related complications. Therefore, there is a current tendency to recommend the endovascular treatment as a standard for the treatment of type B aortic dissection
id SBCCV-1_647b08ca5ad3b412f2a4f8587c09458a
oai_identifier_str oai:scielo:S0102-76382014000300396
network_acronym_str SBCCV-1
network_name_str Brazilian Journal of Cardiovascular Surgery (Online)
repository_id_str
spelling Indication of endovascular treatment of type B aortic dissection - Literature reviewEndovascular ProceduresAortic DiseasesAneurysm, DissectingAortic dissection is a cardiovascular event of high mortality if not early diagnosed and properly treated. In Stanford type A aortic dissection, there is the involvement of the ascending aorta, whereas in type B the ascending aorta is not affected. The treatment of type A aortic dissection is mainly surgical. The hospital mortality of type B aortic dissection surgical treatment is approximately 20%, while medical therapy is 10%. However, half the patients who are discharged from hospital after medical treatment, progress to aortic complications in the following years, and the mortality in three to five years may reach 25-50%. In addition, the surgical treatment of aortic complications after medical treatment, has also a significant mortality. This way, the endovascular treatment comes up as an interesting alternative of a less invasive treatment for this disease. They presented a mortality rate lower than 10% with more than 80% success rate of occlusion and thrombosis of the false lumen. The INSTEAD TRIAL, which randomized patients with uncomplicated type B aortic dissection for optimal medical therapy and endovascular treatment in addition to optimal medical therapy, showed that after three years of follow up, patients who underwent endovascular treatment had lower mortality and aorta-related complications. Therefore, there is a current tendency to recommend the endovascular treatment as a standard for the treatment of type B aortic dissectionSociedade Brasileira de Cirurgia Cardiovascular2014-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000300396Brazilian Journal of Cardiovascular Surgery v.29 n.3 2014reponame:Brazilian Journal of Cardiovascular Surgery (Online)instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)instacron:SBCCV10.5935/1678-9741.20140076info:eu-repo/semantics/openAccessDuarte,João JacksonPontes,José Carlos Dorsa VieiraBenfatti,Ricardo AdalaFerrachini,Adriana LugoKarakhanian,Walter KeghamRazuk Filho,Álvaroeng2014-10-29T00:00:00Zoai:scielo:S0102-76382014000300396Revistahttp://www.rbccv.org.br/https://old.scielo.br/oai/scielo-oai.php||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br1678-97410102-7638opendoar:2014-10-29T00:00Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)false
dc.title.none.fl_str_mv Indication of endovascular treatment of type B aortic dissection - Literature review
title Indication of endovascular treatment of type B aortic dissection - Literature review
spellingShingle Indication of endovascular treatment of type B aortic dissection - Literature review
Duarte,João Jackson
Endovascular Procedures
Aortic Diseases
Aneurysm, Dissecting
title_short Indication of endovascular treatment of type B aortic dissection - Literature review
title_full Indication of endovascular treatment of type B aortic dissection - Literature review
title_fullStr Indication of endovascular treatment of type B aortic dissection - Literature review
title_full_unstemmed Indication of endovascular treatment of type B aortic dissection - Literature review
title_sort Indication of endovascular treatment of type B aortic dissection - Literature review
author Duarte,João Jackson
author_facet Duarte,João Jackson
Pontes,José Carlos Dorsa Vieira
Benfatti,Ricardo Adala
Ferrachini,Adriana Lugo
Karakhanian,Walter Kegham
Razuk Filho,Álvaro
author_role author
author2 Pontes,José Carlos Dorsa Vieira
Benfatti,Ricardo Adala
Ferrachini,Adriana Lugo
Karakhanian,Walter Kegham
Razuk Filho,Álvaro
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Duarte,João Jackson
Pontes,José Carlos Dorsa Vieira
Benfatti,Ricardo Adala
Ferrachini,Adriana Lugo
Karakhanian,Walter Kegham
Razuk Filho,Álvaro
dc.subject.por.fl_str_mv Endovascular Procedures
Aortic Diseases
Aneurysm, Dissecting
topic Endovascular Procedures
Aortic Diseases
Aneurysm, Dissecting
description Aortic dissection is a cardiovascular event of high mortality if not early diagnosed and properly treated. In Stanford type A aortic dissection, there is the involvement of the ascending aorta, whereas in type B the ascending aorta is not affected. The treatment of type A aortic dissection is mainly surgical. The hospital mortality of type B aortic dissection surgical treatment is approximately 20%, while medical therapy is 10%. However, half the patients who are discharged from hospital after medical treatment, progress to aortic complications in the following years, and the mortality in three to five years may reach 25-50%. In addition, the surgical treatment of aortic complications after medical treatment, has also a significant mortality. This way, the endovascular treatment comes up as an interesting alternative of a less invasive treatment for this disease. They presented a mortality rate lower than 10% with more than 80% success rate of occlusion and thrombosis of the false lumen. The INSTEAD TRIAL, which randomized patients with uncomplicated type B aortic dissection for optimal medical therapy and endovascular treatment in addition to optimal medical therapy, showed that after three years of follow up, patients who underwent endovascular treatment had lower mortality and aorta-related complications. Therefore, there is a current tendency to recommend the endovascular treatment as a standard for the treatment of type B aortic dissection
publishDate 2014
dc.date.none.fl_str_mv 2014-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000300396
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000300396
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/1678-9741.20140076
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
dc.source.none.fl_str_mv Brazilian Journal of Cardiovascular Surgery v.29 n.3 2014
reponame:Brazilian Journal of Cardiovascular Surgery (Online)
instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron:SBCCV
instname_str Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron_str SBCCV
institution SBCCV
reponame_str Brazilian Journal of Cardiovascular Surgery (Online)
collection Brazilian Journal of Cardiovascular Surgery (Online)
repository.name.fl_str_mv Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
repository.mail.fl_str_mv ||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br
_version_ 1752126598555893760